Please login to the form below

Not currently logged in
Email:
Password:

Sam Agus takes up new role at Hansa Medical

Will focus on the firm’s lead kidney transplantation project IdeS

Hansa Medical has appointed Sam Agus as it’s new chief medical officer, a role that will see him focus on building an effective company strategy around the global market for the launch of IdeS – a project based on kidney transplants in sensitised patients.

Agus has previously held various leading positions at several pharmaceutical companies including Shire, Solvay Pharmaceuticals, Abbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology.

With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases.

Göran Arvidson, president and CEO of Hansa Medical, said: “We are very pleased to have Sam joining our team in this truly exciting phase for Hansa Medical.

“His experience from building and leading strong teams will be a central part in our next phase towards commercialisation of IdeS.”

Sam Agus succeeds Steven Glazer who will continue to provide strategic advice to Swedish biopharmaceutical firm Hansa.

4th April 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics